As pressures on Canada’s freshwater water supplies grow, the Canadian mining sector is seeking to develop the most sustainable approaches to mining. Dr. Lesley A. Warren of the University of Toronto, along with Dr. Jillian Banfield of University of California, Berkeley, is leading a project that will apply genomics, geochemistry and modeling to mining wastewaters to develop tools to better monitor, manage and reduce sulphur compounds in wastewaters. This project will lower management costs, decrease risk of environmental damage, and better safeguard Canada’s freshwater supplies.
Frontier Agri-Science Inc. and Dr. Dario Bonetta of the University of Ontario Institute of Technology are developing a unique model for both prediction of candidate genes and the validation of effectiveness to improve traits in crops such as wheat, corn and rice. This academic-industry partnership is developing and refining Brachypodium as a highly efficient and novel monocot model system for crop development, with the potential to lead to the development of plant traits with herbicidal tolerance in key food crops.
In response to a need for a simpler, more cost-effective and environmentally responsible solution for treatment of wastewater, Ontario Genomics, alongside an NSERC Engage Plus award, supported a partnership between Bishop Water Technologies (BWT) and Dr. Christopher Weisener and his colleague Dr.Rao Chaganti of the University of Windsor. They are working together to find a solution for BWT’s product, BioCord, that would be affordable to communities, environmentally responsible, simpler to operate, and compliant with Federal and existing provincial regulations.
Personalized Medicine is an approach to health care in which treatment is informed by a deep understanding of the genomic and other molecular changes that contribute to the disease. The concept of Personalized Medicine is embodied by the expression “the right medicine to the right person at the right dose and at the right time.”
Dr. Peter Liu of the University of Ottawa Heart Institute discusses his research, which, through a partnership with Roche Diagnostics, is working to develop a novel heart failure biomarker panel that accurately diagnoses and classifies the disease. This solution enables physicians to select the best and the right treatment for individual patients.
As leaders in identifying the potential for, and investing in the development of early-stage genomics and proteomics discoveries, we are often the first to invest in winning ideas that will be attractive to later-stage investors for commercialization of the technology. Through our demand-pull model, along with our affiliation with Genome Canada, we’ve successfully identified, nurtured…
A 2015 video testimony from Don Bishop of Bishop Water Technologies (BWT) describing how genomics can be a solution to make wastewater plants more effective and cheaper. Specifically, he talks about his organization’s experience using metagenomics to help improve and optimize BWT’s “BioCord” technology for municipal and industrial wastewater treatment.
Every organ and type of tissue in the body contains a small number of what scientists call “adult” or “tissue” stem cells. Since most cells in the body live for just a short time, the body needs to keep making new cells to replace them. Adult stem cells ensure a continuous supply of new cells…
Type 1 diabetes is a disease in which the pancreas does not produce insulin, resulting in glucose accumulation in the blood instead of being used for energy. The Challenge Type 1 Diabetes (T1D) is a complex disease often arising in childhood in which the immune system destroys the insulin producing cells of the pancreas. Insulin…
Water contaminants can lead to deadly diseases such as dengue fever, cholera, dysentery, and diarrhea. DNA-based technologies can quickly and accurately detect pathogens in a water supply, identifying unsafe water before it can make people sick. KB-1 is a value-recovery tool for contaminated groundwater discovered by Dr. Elizabeth Edwards of the University of Toronto and now marketed and sold by SiREM, which is being adapted to identify a variety of contaminants, applicable across the unique conditions of developing countries.